Ex-Genzyme CFO takes up exec chair role at subcutaneous delivery specialistnews2021-07-27T10:26:09+00:00July 27th, 2021|Fierce Pharma|
Stada scores rights to targeted oral steroid under review for an autoimmune kidney diseasenews2021-07-27T10:22:52+00:00July 27th, 2021|Fierce Pharma|
Otsuka’s dispersible TB drug for kids wins CHMP supportnews2021-07-27T10:17:22+00:00July 27th, 2021|Fierce Pharma|
AstraZeneca edges out in front of competition with FDA nod for once-weekly diabetes drug in kidsnews2021-07-27T10:11:56+00:00July 27th, 2021|Fierce Pharma|
‘Godmother of Soul’ joins pharma-backed campaign to boost cancer screenings after pandemic dropoffnews2021-07-27T00:05:54+00:00July 27th, 2021|Fierce Pharma|
As GlaxoSmithKline works to get Shingrix back on track, an FDA approval increases the key vaccine’s reachnews2021-07-26T20:08:55+00:00July 26th, 2021|Fierce Pharma|
Emergent’s new opioid awareness campaign taps NFL’s Darren Waller to tackle overdose stigmanews2021-07-26T19:43:38+00:00July 26th, 2021|Fierce Pharma|
Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed termsnews2021-07-26T15:36:03+00:00July 26th, 2021|Fierce Pharma|
Look out, Lilly: Biogen’s Aduhelm likely won’t be the only Alzheimer’s med subject to Medicare’s coverage reviewnews2021-07-26T15:17:10+00:00July 26th, 2021|Fierce Pharma|
Better together: McCann and FCB health chiefs talk strategy and strengths in creating IPG Healthnews2021-07-26T14:33:12+00:00July 26th, 2021|Fierce Pharma|
